Evaluation of interferences between dengue vaccine serotypes in a monkey model

Area of Science:

• Vaccinology
• Immunology
• Virology

Background:

• Interference between vaccine antigens can impact immunogenicity.
• Previous studies have reported such interferences in various vaccine formulations, including polio and dengue vaccines.

Purpose of the Study:

• To investigate antigenic interference among the four serotypes of ChimeriVax dengue vaccines (CYDs) in a tetravalent formulation (TV-5555).
• To identify parameters that influence these interferences in a non-human primate model.

Main Methods:

• Non-human primates were vaccinated with a tetravalent dengue vaccine formulation (TV-5555).
• Immunoassays were performed to measure neutralizing antibody levels against different dengue serotypes.
• Various administration strategies and formulation adjustments were evaluated for their impact on immune responses.

Main Results:

• Dengue serotype 4 (DEN-4) induced dominant neutralizing antibody responses, followed by DEN-1.
• Identified factors influencing interference included administration timing, prior flavivirus exposure, dose adjustments of dominant serotypes, and booster immunizations.
• Simultaneous or sequential administration of bivalent vaccines and pre-existing heterologous flavivirus immunity modulated responses.

Conclusions:

• Antigenic interference is a significant factor in tetravalent dengue vaccine formulations.
• Strategies such as adjusting immunodominant serotype doses, optimizing administration schedules, and considering pre-existing immunity can mitigate interference.
• Findings provide insights for optimizing dengue vaccine design and human applicability.